Clinical Trials Sponsored by Scottsdale Healthcare

Total 4419 results

Baxter Healthcare Corporation

Terminated

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Acute Kidney Injury | Regional Citrate Anticoagulation (RCA) | Continuous Renal Replacement Therapy (CRRT)

United States, Canada
Helsinn Healthcare SA

Completed

Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®

Quality of Life | Radiodermatitis

Italy
ViiV Healthcare
GlaxoSmithKline

Completed

Dolutegravir Expanded Access Study (DEAP)

HIV Infections | Infection, Human Immunodeficiency Virus

France, Germany, United States, Canada, Belgium, Austria, Brazil, Italy, Poland
Qure Healthcare, LLC

Completed

Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study

Prostate Cancer

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers

HIV Infections

United States
Baxter Healthcare Corporation

Completed

Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding (CELSTAT)

Bleeding Active

United States, Czechia, Germany, Poland
Gama Healthcare Ltd.

Completed

An Evaluation of the Efficacy of HEXI-PREP by Clinell Wipes

Antimicrobial Effect

United Kingdom
St Elizabeth Healthcare

Unknown

A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence (REACH)

Non-small Cell Lung Cancer

United States
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

End Stage Renal Disease

China
Baxter Healthcare Corporation

Completed

Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis Comparing the Theranova Dialyzer to Hemodiafiltration

End Stage Renal Disease

China
ViiV Healthcare
GlaxoSmithKline

Completed

PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

Infection, Human Immunodeficiency Virus I
ViiV Healthcare
GlaxoSmithKline

Completed

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

HIV Infections | Infection, Human Immunodeficiency Virus

Germany
St Elizabeth Healthcare

Completed

Impact of an Intensive Monitoring Strategy in Symptomatic Patients With Suspected Arrhythmia (IMPACT)

Suspected Arrhythmia

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Drug Exposure Registry for GSK2248761, an Investigational NNRTI

HIV Infections
Seton Healthcare Family

Completed

Topical Steroid Formulation and Wet Wraps

Dermatitis, Atopic

United States
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD | CAPD | APD

Taiwan, Korea, Republic of, Singapore, Hong Kong, Russian Federation
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD

Australia, Canada, New Zealand
ViiV Healthcare
GlaxoSmithKline

Completed

Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany (TRIUMPH)

HIV Infections

Germany
ViiV Healthcare
Pfizer

Terminated

Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay

HIV Infections

United States, Canada
ViiV Healthcare
GlaxoSmithKline

Completed

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Infection, Human Immunodeficiency Virus

Argentina
ViiV Healthcare
Pfizer

No longer available

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Human Immunodeficiency Virus (HIV)
ViiV Healthcare
GlaxoSmithKline

Terminated

Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults

Infection, Human Immunodeficiency Virus

United States, France, Germany, Canada, Spain, United Kingdom, Mexico, Italy, Argentina, Chile, South Africa, Poland
Helsinn Healthcare SA

Completed

Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Meuhedet. Healthcare Organization

Completed

SMS Reminders for Positive FOBT Follow-up

Colorectal Cancer
Seton Healthcare Family

Completed

PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei

Scabies

United States
Vinmec Healthcare System

Completed

Erector Spinae Plane Block and Pain Management in Cardiac Surgery (ESPCATHEART)

Cardiac Surgery | Adult

Vietnam
Vinmec Healthcare System

Completed

Outcomes of Stem Cells for Cerebral Palsy

Cerebral Palsy

Vietnam
Baxter Healthcare Corporation

Terminated

Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis

Gastroenteritis | Dehydration

United States, Canada
ViiV Healthcare
GlaxoSmithKline

Completed

Fosamprenavir Versus Other Protease Inhibitors

Infection, Human Immunodeficiency Virus I

United States, Puerto Rico
ViiV Healthcare
GlaxoSmithKline

Completed

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects (FLAMINGO)

Infection, Human Immunodeficiency Virus

Spain, France, Germany, United States, Italy, Romania, Russian Federation, Switzerland, Puerto Rico
Reengineering Healthcare Inc.

Completed

Randomized Trial of the Impact of Body Scanning and Intensive Behavioral Intervention on Behavioral Change and Health Outcomes

Coronary Disease | Hypertension | Hypercholesterolemia | Behavior and Behavior Mechanisms
ViiV Healthcare
GlaxoSmithKline

Completed

A Open-label, Drug-Drug Interaction With Maraviroc (DDI)

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701

Infection, Human Immunodeficiency Virus

United Kingdom
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy Subjects

Infection, Human Immunodeficiency Virus

United States
Baxter Healthcare Corporation

Completed

Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions

Intraperitoneal Adhesions

Denmark, Poland, Sweden
Baxter Healthcare Corporation

Completed

Necklace-Shaped Sensor for Non-Invasive Monitoring of Stroke Volume and Cardiac Output

Heart Failure
Baxter Healthcare Corporation

Completed

Effects of IV Chloride Content on Outcomes

SIRS | Balanced Fluids | Plasmalyte

United States
ViiV Healthcare
GlaxoSmithKline

Completed

GSK1349572 Relative Bioavailability Study

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435

Infection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and Herpesviridae

United States
Baxter Healthcare Corporation

Withdrawn

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

Peritoneal Dialysis | Hypertriglyceridemia

United States
Seton Healthcare Family

Completed

Efficacy of Tyrosine in Restless Legs Syndrome

Restless Legs Syndrome (RLS)

United States
Baxter Healthcare Corporation

Completed

Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients

Deep Partial or Full Thickness Wounds

United States
ViiV Healthcare
Pfizer

Completed

THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC

Healthy Subjects

United States
ViiV Healthcare
GlaxoSmithKline

No longer available

An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc

Infection, Human Immunodeficiency Virus

Belgium, Russian Federation, Italy, South Africa, Argentina, Switzerland, Poland
ViiV Healthcare
GlaxoSmithKline

Completed

Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations

Infection, Human Immunodeficiency Virus

United States
Tabula Rasa HealthCare

Completed

Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice (EMTM)

Pharmacogenomics | Medication Therapy Management

United States
OSF Healthcare System

Completed

Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study (MISPACE)

Intracerebral Hemorrhage

United States
Philips Oral Healthcare

Completed

Efficacy and Safety Study of Interproximal Cleaning Modalities on Oral Health

Gingivitis

United States
Helsinn Healthcare SA

Completed

Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy

Cancer | Nausea | Vomiting

Italy
ViiV Healthcare
Pfizer

Terminated

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 (MODERN)

HIV-1

United States, Netherlands, Spain, Puerto Rico, Canada, Australia, Germany, Sweden, Poland, Portugal, Switzerland, France, Denmark, Italy, Belgium, United Kingdom, Hungary, Austria, Finland

Clinical Trials Sponsored by Scottsdale Healthcare

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations